|Articles|December 1, 2005

Pharmacy Times

  • Volume 0
  • 0

US Rx Drug Sales to Skyrocket During 2006

Author(s)Ken Rankin

The new Medicare Part D prescriptiondrug program is expected to triggera sharp increase in the demand forRx medicines during the coming year,researchers at IMS Health predict. USsales of prescription drugs are projectedto grow by between 8% and 9% in2006—an increase almost 50% greaterthan the worldwide rise in demandfor medicines and double the salesgrowth expected for many Europeancountries.

Currently, US sales of prescriptiondrugs total $230 billion, or 43% of theworldwide market for these products.The upsurge in demand next year figuresto push the US share of the globalpharmaceutical market even higher,according to IMS Health.

Mr. Rankin is a freelance medical writer.

Articles in this issue


Related to this article

mRNA vaccine bottles and syringes for preventing coronavirus or covid-19 - Image credit: kitsawet | stock.adobe.com
Despite the controversy surrounding mRNA's role in the COVID-19 response, the technology's broader promise—to prevent, treat, and even cure a host of diseases—is coming into focus.